Clinical Trial Update: To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing immediate-release tacrolimus (Prograf) and Astagraf XL to assess donor-specific antibody formation and immune activation in de …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Astagraf XL (Tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2020-06-29